Anuja Healthcare Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 28-06-2024
- Paid Up Capital ₹ 7.42 M
as on 28-06-2024
- Company Age 27 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 21.31 Cr
as on 28-06-2024
- Satisfied Charges ₹ 57.78 Cr
as on 28-06-2024
- Revenue 50.50%
(FY 2023)
- Profit 13.37%
(FY 2023)
- Ebitda 2.20%
(FY 2023)
- Net Worth 2.60%
(FY 2023)
- Total Assets 21.71%
(FY 2023)
About Anuja Healthcare
The Corporate was formerly known as Anuja Impex Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.42 M.
The company currently has active open charges totaling ₹21.31 Cr. The company has closed loans amounting to ₹57.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kemat Rai, Manoj Prasad, and Maan Singh serve as directors at the Company.
- CIN/LLPIN
U51909CH1997PLC019585
- Company No.
019585
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Mar 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Anuja Healthcare?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kemat Rai | Managing Director | 19-Apr-1997 | Current |
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Manoj Prasad | Director | 14-May-2020 | Current |
Maan Singh | Director | 27-Oct-2020 | Current |
Financial Performance of Anuja Healthcare.
Anuja Healthcare Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 50.5% increase. The company also saw a substantial improvement in profitability, with a 13.37% increase in profit. The company's net worth moved up by a moderate rise of 2.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Anuja Healthcare?
In 2023, Anuja Healthcare had a promoter holding of 95.47% and a public holding of 4.53%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 17 Sep 2022 | ₹4.36 Cr | Open |
Others Creation Date: 17 Sep 2022 | ₹16.95 Cr | Open |
The South Indian Bank Limited Creation Date: 19 Feb 2022 | ₹1.30 Cr | Satisfied |
How Many Employees Work at Anuja Healthcare?
Anuja Healthcare has a workforce of 11 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anuja Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anuja Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.